Piperazine Market Size, Share & Trend Analysis Report
商品番号 : SMB-74632
出版社 | Grand View Research |
出版年月 | 2025年2月 |
ページ数 | 80 |
価格タイプ | シングルユーザライセンス |
価格 | USD 5,950 |
種別 | 英文調査報告書 |
Piperazine Market Growth & Trends
The global piperazine market size is anticipated to reach USD 4,024 million by 2030 and is projected to grow at a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is attributable to its wide use in pharmaceuticals (antiparasitic drugs, etc.), agrochemicals (herbicides, pesticides), and various chemical processes.
Grand View Research, Inc. の新しいレポートによると、世界のピペラジンの市場規模は 2030 年までに 40 億 2,400 万米ドルに達すると予想されており、2025 年から 2030 年にかけて 4.1% の CAGR で成長すると予測されています。これは、医薬品 (駆虫薬など)、農薬 (除草剤、殺虫剤)、およびさまざまな化学プロセスで広く使用されていることに起因しています。
The demand for synthetic piperazine is rising due to its crucial role in manufacturing various pharmaceuticals, including antiparasitic drugs and some antipsychotics. Its use as a key intermediate in producing agrochemicals like herbicides and pesticides also fuels market growth, driven by increasing agricultural needs. Furthermore, synthetic piperazine’s applications extend to diverse chemical industries, where it’s used in making polymers, resins, and other materials. This versatility across multiple sectors, coupled with increasing health concerns and agricultural demands, is driving the expansion of the synthetic piperazine industry.
合成ピペラジンの需要は、抗寄生虫薬や一部の抗精神病薬など、さまざまな医薬品の製造に重要な役割を果たしているため、高まっています。除草剤や殺虫剤などの農薬を製造する際の重要な中間体としての使用も、農業ニーズの高まりに牽引されて市場の成長を後押ししています。さらに、合成ピペラジンの用途はさまざまな化学産業に広がっており、ポリマー、樹脂、その他の材料の製造に使用されています。複数の分野にわたるこの汎用性と、高まる健康への懸念および農業需要が相まって、合成ピペラジン産業の拡大を牽引しています。

The agrochemicals industry relies heavily on piperazine due to its essential role in synthesizing various crop protection chemicals. As a key building block, piperazine contributes to the effectiveness of herbicides that control weeds, pesticides that combat insects, and fungicides that prevent fungal diseases. The increasing global population, coupled with the need for higher crop yields to meet food demands, necessitates the widespread use of these agrochemicals. This, in turn, fuels the demand for piperazine as a vital raw material in their production.
The demand for piperazine in North America is on the rise, fueled by a confluence of factors. The region’s robust pharmaceutical sector heavily relies on piperazine for synthesizing various medications, including antiparasitic drugs, contributing significantly to its demand. Simultaneously, the thriving agricultural sector depends on piperazine-derived agrochemicals like herbicides and pesticides to safeguard crops and ensure food security, further driving its consumption.
Some of the prominent players in the Piperazine industry include Evonik Industries, Solvay S.A., Dow, ExxonMobil Corporation, BASF SE, Albemarle Corporation, Shell, and Huntsman Corporation.
Piperazine Market Report Scope
Report Attribute | Details |
Market size value in 2025 | USD 3,296.35 million |
Revenue forecast in 2030 | USD 4,024.08 million |
Growth rate | CAGR of 4.1% from 2025 to 2030 |
Base year for estimation | 2024 |
Historical data | 2018 – 2023 |
Forecast period | 2025 – 2030 |
Quantitative units | Revenue in USD million/billion, and CAGR from 2025 to 2030 |
Report coverage | Revenue forecast, competitive landscape, growth factors, and trends |
Segments covered | Source, end-use, region |
Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope | U.S.; Canada; Mexico; Germany; UK; France; China; India; Japan; Brazil; Argentina; Saudi Arabia; South Africa. |
Key companies profiled | Evonik Industries; Solvay S.A.; Dow; ExxonMobil Corporation; BASF SE; Albemarle Corporation; Shell; Huntsman Corporation |
Customization scope | Free report customization (equivalent to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Piperazine Market Report Highlights
- The natural segment is expected to grow at the fastest CAGR of 4.2% during the forecast period. The demand for natural piperazine is growing due to increasing consumer preference for bio-based and sustainable products in various applications.
- Based on end use, the pharmaceutical segment is expected to grow at the fastest CAGR of 4.6% during the forecast period. Piperazine demand in the pharmaceutical sector is growing due to its crucial role in synthesizing various drugs, including antiparasitic medications, antihistamines, and antipsychotics. The increasing prevalence of parasitic infections and mental health disorders further fuels this demand.
- North America is expected to grow at the fastest CAGR of 4.4% during the forecast period. This growth is attributed to the region’s strong pharmaceutical and agrochemical sectors, where it’s crucial for drug synthesis and pesticide production. In addition, a growing chemical industry and increasing health awareness further contribute to the demand.
- In January 2023, BASF SE acquired Pharmacy Laboratories, a Chinese manufacturer of piperazine and other pharmaceutical intermediates, for USD 30 million. The acquisition helped BASF to expand its presence in the Chinese market and increase its product portfolio in the piperazine segment.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Information Analysis
1.3.2. Market Formulation & Data Visualization
1.3.3. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. Market Variables, Trends, and Scope
3.1. Global Piperazine Market Outlook
3.2. Value Chain Analysis
3.2.1. Raw Material Outlook
3.2.2. Manufacturing/Source Outlook
3.2.3. Sales Channel Analysis
3.3. Price Trend Analysis
3.3.1. Factors Influencing Prices
3.4. Regulatory Framework
3.4.1. Standards & Compliances
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.2. Market Restraint Analysis
3.5.3. Market Challenges Analysis
3.5.4. Market Opportunity Analysis
3.6. Porter’s Five Forces Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of Substitution
3.6.4. Threat of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTLE Analysis
3.7.1. Political
3.7.2. Economic
3.7.3. Social Landscape
3.7.4. Source
3.7.5. Environmental
3.7.6. Legal
Chapter 4. Piperazine Market: Source Estimates & Trend Analysis
4.1. Piperazine Market: Source Movement Analysis, 2024 & 2030
4.2. Natural
4.2.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
4.3. Synthetic
4.3.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 5. Piperazine Market: End Use Estimates & Trend Analysis
5.1. Piperazine Market: End Use Movement Analysis, 2024 & 2030
5.2. Pharmaceutical
5.2.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
5.3. Agrochemicals
5.3.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
5.4. Personal Care & Cosmetics
5.4.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
5.5. Other End Uses
5.5.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 6. Piperazine Market: Regional Estimates & Trend Analysis
6.1. Regional Analysis, 2024 & 2030
6.2. North America
6.2.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.2.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.2.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.2.4. U.S.
6.2.4.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.2.4.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.2.4.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.2.5. Canada
6.2.5.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.2.5.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.2.5.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.2.6. Mexico
6.2.6.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.2.6.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.2.6.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.3. Europe
6.3.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.3.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.3.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.3.4. Germany
6.3.4.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.3.4.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.3.4.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.3.5. UK
6.3.5.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.3.5.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.3.5.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.3.6. France
6.3.6.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.3.6.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.3.6.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.4.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.4.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.4.4. China
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.4.4.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.4.4.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.4.5. India
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.4.5.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.4.5.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.4.6. Japan
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.4.6.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.4.6.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.5. Latin America
6.5.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.5.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.5.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.5.4. Brazil
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.5.4.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.5.4.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.5.5. Argentina
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.5.5.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.5.5.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.6. Middle East & Africa
6.6.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.6.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.6.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.6.4. Saudi Arabia
6.6.4.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.6.4.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.6.4.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
6.6.5. South Africa
6.6.5.1. Market estimates and forecasts, 2018 – 2030 (USD Million)
6.6.5.2. Market estimates and forecasts, by source, 2018 – 2030 (USD Million)
6.6.5.3. Market estimates and forecasts, by end use, 2018 – 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Market Positioning Analysis, 2024
7.5. Strategy Mapping
7.6. Company Profiles/Listing
7.6.1. BASF SE
7.6.1.1. Company Overview
7.6.1.2. Financial Performance
7.6.1.3. Source Benchmarking
7.6.2. Evonik Industries
7.6.2.1. Company Overview
7.6.2.2. Financial Performance
7.6.2.3. Source Benchmarking
7.6.3. Dow
7.6.3.1. Company Overview
7.6.3.2. Financial Performance
7.6.3.3. Source Benchmarking
7.6.4. Solvay S.A.
7.6.4.1. Company Overview
7.6.4.2. Financial Performance
7.6.4.3. Source Benchmarking
7.6.5. ExxonMobil Corporation
7.6.5.1. Company Overview
7.6.5.2. Financial Performance
7.6.5.3. Source Benchmarking
7.6.6. Albemarle Corporation
7.6.6.1. Company Overview
7.6.6.2. Financial Performance
7.6.6.3. Source Benchmarking
7.6.7. Shell
7.6.7.1. Company Overview
7.6.7.2. Financial Performance
7.6.7.3. Source Benchmarking
7.6.8. Huntsman Corporation
7.6.8.1. Company Overview
7.6.8.2. Financial Performance
7.6.8.3. Source Benchmarking
List of Tables
Table 1 Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 2 Natural Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 3 Synthetic Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 4 Piperazine market estimates & forecasts, in pharmaceutical, 2018 – 2030 (USD Million)
Table 5 Piperazine market estimates & forecasts, by agrochemical, 2018 – 2030 (USD Million)
Table 6 Piperazine market estimates & forecasts, by personal care & cosmetics, 2018 – 2030 (USD Million)
Table 7 Piperazine market estimates & forecasts, by other end uses, 2018 – 2030 (USD Million)
Table 8 Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 9 Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 10 Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 11 North America polyurethane Coatings market estimates & forecast, 2018 – 2030 (USD Million)
Table 12 North America Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 13 North America Piperazine market estimates & forecasts by application, 2018 – 2030 (USD Million)
Table 14 U.S. Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 15 U.S. Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 16 U.S. Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 17 Canada Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 18 Canada Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 19 Canada Piperazine market estimates & forecasts by end use, 2018 – 2030 (Kilotons)
Table 20 Canada Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 21 Mexico Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 22 Mexico Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 23 Mexico Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 24 Europe Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 25 Europe Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 26 Europe Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 27 Germany Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 28 Germany Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 29 Germany Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 30 Uk Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 31 Uk Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 32 Uk Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 33 France Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 34 France Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 35 France Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 36 Asia pacific Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 37 Asia pacific Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 38 Asia pacific Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 39 China Piperazine market estimates & forecast, 2018 – 2030 (USD Million)
Table 40 China Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 41 China Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 42 India Piperazine market estimates & forecast, 2018 – 2030 (USD Million)
Table 43 India Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 44 India Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 45 Japan Piperazine market estimates & forecast, 2018 – 2030 (USD Million)
Table 46 Japan Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 47 Japan Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 48 South Korea Piperazine market estimates & forecast, 2018 – 2030 (USD Million)
Table 49 South Korea Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 50 South Korea Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 51 Latin America Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 52 Latin America Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 53 Latin America Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 54 Brazil Piperazine market estimates & forecast, 2018 – 2030 (USD Million)
Table 55 Brazil Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 56 Brazil Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 57 Argentina Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 58 Argentina Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 59 Argentina Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 60 Middle East & Africa Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 61 Middle East & Africa Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 62 Middle East & Africa Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 63 Saudi Arabia Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 64 Saudi Arabia Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 65 Saudi Arabia Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
Table 66 South Africa Piperazine market estimates & forecasts, 2018 – 2030 (USD Million)
Table 67 South Africa Piperazine market estimates & forecasts by source, 2018 – 2030 (USD Million)
Table 68 South Africa Piperazine market estimates & forecasts by end use, 2018 – 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Information procurement
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Data validating & publishing
Fig. 6 Market snapshot
Fig. 7 Segmental outlook –End Use & Source
Fig. 8 Competitive Outlook
Fig. 9 Piperazine market outlook, 2018–2030 (USD Million)
Fig. 10 Value chain analysis
Fig. 11 Market dynamics
Fig. 12 Porter’s Analysis
Fig. 13 PESTEL Analysis
Fig. 14 Piperazine market, by source: Key takeaways
Fig. 15 Piperazine market, by source: Market share, 2024 & 2030
Fig. 16 Piperazine market, by end use: Key takeaways
Fig. 17 Piperazine market, by end use: Market share, 2024 & 2030
Fig. 18 Piperazine market: Regional analysis, 2024
Fig. 19 Piperazine market, by region: Key takeaways
Grand View Researchについて
Grand View Research(グランドビューリサーチ) はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ 1
シングルユーザ | チーム | エンタープライズ |
USD 2,950 | USD 3,950 | USD 5,950 |
ライセンスタイプ 2
シングルユーザ | チーム | エンタープライズ |
USD 3,950 | USD 4,950 | USD 6,950 |
ライセンスタイプ 3
シングルユーザ | チーム | エンタープライズ |
USD 4,950 | USD 5,950 | USD 7,950 |
ライセンスタイプ 4
シングルユーザ | チーム | エンタープライズ |
USD 5,950 | USD 6,950 | USD 8,950 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス(インディビジュアルライセンス)
- 1名のみレポートファイル(印刷不可)をご利用いただけます。
- チームライセンス
- 同一企業(関連会社除く)内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
- コーポレートライセンス
- 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
- 「関連会社」の範囲についてはお気軽にお問い合わせください。
- シングルユーザライセンス(インディビジュアルライセンス)
- 納品形態
- オンラインダウンロード
- 納期
- ご注文後1~7営業日 ※レポートにより異なります。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
最新出版レポート